RT Journal Article
T1 [Position statement of the Spanish Association of Paediatrics-Spanish Society of Paediatric Infectious Diseases (AEP-SEIP) on the treatment of multidrug-resistant bacterial infections].
T2 Documento de posicionamiento de la Asociación Española de Pediatría-Sociedad Española de Infectología Pediátrica (AEP-SEIP) sobre el tratamiento de las infecciones por bacterias multirresistentes.
A1 Aguilera-Alonso, David
A1 Escosa-García, Luis
A1 Goycochea-Valdivia, Walter Alfredo
A1 Soler-Palacín, Pere
A1 Saavedra-Lozano, Jesús
A1 Rodrigo, Carlos
A1 Cercenado, Emilia
A1 Ramos, José Tomás
A1 Baquero-Artigao, Fernando
K1 AmpC β-lactamases
K1 Antimicrobial resistance
K1 Bacterias multirresistentes
K1 Carbapenemasas
K1 Carbapenemases
K1 Enterococcus
K1 Extended-spectrum β-lactamases
K1 Methicillin-resistant Staphylococcus aureus
K1 Pseudomonas aeruginosa
K1 Staphylococcus aureus resistente a meticilina
K1 β-lactamasas AmpC
K1 β-lactamasas de espectro extendido
AB A progressive increase in the incidence of infections caused by multidrug-resistant microorganisms is being reported. Among these resistant microorganisms, the main threats are extended-spectrum β-lactamase-, AmpC-, and carbapenemase-producing Gram-negative bacilli, methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium. To address this important problem, it is essential to establish pediatric Antimicrobial Stewardship programs, perform active epidemiological surveillance and develop an adequate infection control policy. The therapeutic approach of these infections is often complex, frequently requiring antibiotics with less experience in children. In this position document made by the Spanish Association of Pediatrics and the Spanish Society of Pediatric Infectious Diseases, the epidemiology and treatment of these infections are reviewed according to the best available evidence.
YR 2019
FD 2019-10-19
LK http://hdl.handle.net/10668/15056
UL http://hdl.handle.net/10668/15056
LA es
DS RISalud
RD Apr 12, 2025